Diltiazem inhibition of cytochrome P-450 3A activity is due to metabolite intermediate complex formation.
J Pharmacol Exp Ther. 1999 Sep;290(3):1116-25.
J Pharmacol Exp Ther. 1999.
PMID: 10454485